mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease.

Autor: Wege AK; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany., Rom-Jurek EM; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany., Jank P; Institute of Pathology, Philipps-University Marburg, UKGM University Hospital Marburg, Marburg, Germany., Denkert C; Institute of Pathology, Philipps-University Marburg, UKGM University Hospital Marburg, Marburg, Germany., Ugocsai P; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany., Solbach C; Department of Gynecology and Obstetrics, University Hospital Frankfurt, Frankfurt, Germany., Blohmer JU; Breast Cancer Center, Charité Universitätsmedizin Berlin, Berlin, Germany., Sinn B; Breast Cancer Center, Charité Universitätsmedizin Berlin, Berlin, Germany., van Mackelenbergh M; Department of Gynecology and Obstetrics, Schleswig-Holstein University Hospital, Kiel, Germany., Möbus V; Department of Medicine II, Hematology and Oncology, Goethe University of Frankfurt, Frankfurt, Germany., Trumpp A; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), German Cancer Consortium (DKTK), Heidelberg, Germany., Marangoni E; Department of Translational Research, Institute Curie, PSL Research University, Paris, France., Pfarr N; Institute of Pathology, Technical University Munich, Munich, Germany., Irlbeck C; Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany.; Department of Experimental Medicine, University of Regensburg, Regensburg, Germany., Warfsmann J; Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany.; Department of Experimental Medicine, University of Regensburg, Regensburg, Germany., Polzer B; Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany.; Department of Experimental Medicine, University of Regensburg, Regensburg, Germany., Weber F; Institute of Pathology, University of Regensburg., Ortmann O; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany., Loibl S; German Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany., Vladimirova V; German Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany., Brockhoff G; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany.

Publikováno v: International journal of cancer [Int J Cancer] 2022 Apr 15; Vol. 150 (8), pp. 1357-1372. Date of Electronic Publication: 2021 Dec 28.

CCR7 Is Important for Mesangial Cell Physiology and Repair.

Autor: Wurm S; Department of Nephrology, University Hospital Regensburg, Regensburg, Germany., Steege A; Department of Nephrology, University Hospital Regensburg, Regensburg, Germany., Rom-Jurek EM; Department of Nephrology, University Hospital Regensburg, Regensburg, Germany.; Department of Gynaecology and Obstetrics, University Hospital Regensburg, Regensburg, Germany., van Roeyen CR; Division of Nephrology and Immunology, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany., Kurtz A; Institute of Physiology, University of Regensburg, Regensburg, Germany., Banas B; Department of Nephrology, University Hospital Regensburg, Regensburg, Germany., Banas MC; Department of Nephrology, University Hospital Regensburg, Regensburg, Germany.

Publikováno v: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society [J Histochem Cytochem] 2018 Jan; Vol. 66 (1), pp. 7-22. Date of Electronic Publication: 2017 Oct 27.